Amedica Corporation (AMDA) 0.84 $AMDA
Amedica Corporation to Release Second Quarter 2016 Financial Results and Host Conference Call
Marketwire Canada - Mon Aug 01, 11:39AM CDT
SALT LAKE CITY, UT--(Marketwired - Aug 1, 2016) - Amedica Corporation (NASDAQ: AMDA), a company that develops and commercializes silicon nitride ceramics as a biomaterial platform, announced today that it will release financial results for its second quarter 2016 on Thursday, August 11, 2016, after the market closes.
AMDA: 0.84 (+0.01)
Why Investors Love These Medical Appliances & Equipment's Stocks? - Align Technology, ZELTIQ Aesthetics, Amedica, and Nxstage Medical
PR Newswire - Wed Jun 22, 6:45AM CDT
Growth is expected for the U.S. Medical Appliances and Equipment industry as demand for healthcare continues to rise. In today's pre-market research, Stock-Callers.com shifts its attention on these four equities for investors' close review: Align Technology Inc. (NASDAQ: ALGN), ZELTIQ Aesthetics Inc. (NASDAQ: ZLTQ), Amedica Corp. (NASDAQ: AMDA), and Nxstage Medical Inc. (NASDAQ: NXTM). Learn more about these stocks and receive your complimentary trade alerts at:
NXTM: 22.09 (-0.02), ZLTQ: 33.57 (-0.38), ALGN: 89.69 (+0.54), AMDA: 0.84 (+0.01)
Amedica Corporation Reports First Quarter 2016 Financial Results
Marketwire Canada - Thu May 12, 3:25PM CDT
Q1 Operational Cash Burn Improved by 51% Year-Over-Year
AMDA: 0.84 (+0.01)
Amedica Completes Debt Exchange and Reduces Debt Obligations by 47% Year-Over-Year
Marketwired - Tue May 03, 8:15AM CDT
Amedica Corporation (NASDAQ: AMDA), a company that develops and commercializes silicon nitride ceramics as a biomaterial platform, is pleased to announce it has reduced its total debt obligations to $12.9 million, a decrease of 47% from the prior year period, with the completion of the previously announced $3.0 million debt exchange.
AMDA: 0.84 (+0.01)
Amedica Corporation to Release First Quarter 2016 Financial Results and Host Conference Call
Marketwired - Fri Apr 29, 3:30PM CDT
Amedica Corporation (NASDAQ: AMDA), a company that develops and commercializes silicon nitride ceramics as a biomaterial platform, announced today that it will release financial results for its first quarter 2016 on Thursday, May 12, 2016, after the market closes.
AMDA: 0.84 (+0.01)
Amedica Signs Exclusive Chinese Silicon Nitride Distribution Agreement
Marketwired - Mon Apr 18, 8:15AM CDT
Amedica Corporation (NASDAQ: AMDA), a company that develops and commercializes silicon nitride ceramics as a biomaterial platform, is pleased to announce a partnership with Shandong Weigao Orthopedic Device Company Limited ("Weigao Orthopedic"
, a subsidiary of Shandong Weigao Group Medical Polymer Company Limited (HKSE: 1066), a medical device company in China specializing in the R&D, production and sale of spine, trauma and joint orthopedic implants.
AMDA: 0.84 (+0.01)
Positive Economic Trends Bode Well for Manufacturers, According to Keynote on Day Two of IQMS Pinnacle User Conference
BusinessWire - Thu Apr 07, 3:00PM CDT
The US and international economies are having some impact on the demand for manufactured goods, but positive trends--including a spike in future orders--point to growth in the manufacturing sector. That was theme of the keynote on Day Two of the Pinnacle conference for customers of IQMS, a leading manufacturing ERP software and manufacturing execution system (MES) authority. The keynote session, "Five Reasons to Set Your Hair on Fire and Five Directions to Chill," was delivered by Dr. Christopher Kuehl, co-founder, managing director, and the lead economic analyst at Armada Corporate Intelligence.
AMDA: 0.84 (+0.01)
Amedica Enters Debt Exchange Agreement
Marketwired - Tue Apr 05, 8:15AM CDT
Amedica Corporation (NASDAQ: AMDA), a company that develops and commercializes silicon nitride ceramics as a biomaterial platform, is pleased to announce it has entered into a debt exchange agreement with Riverside Merchant Partners, LLC, Hercules Technology III, L.P. and Hercules Capital, Inc. Amedica agreed to exchange $1.0 million of the principal amount outstanding under the term loan held by Riverside for a subordinated convertible promissory note in the principal amount of $1.0 million and a warrant to purchase 100,000 shares of common stock. The subordinated convertible promissory note is convertible into shares of common stock at a fixed conversion price of $1.43 and the exercise price of the warrant is fixed at $1.62 per share. The subordinated convertible promissory note bears interest at a rate of 6% per annum and is due March 3, 2018.
AMDA: 0.84 (+0.01)
Bioceramics Market Analysis - Key Players are CeramTec, Amedica Corporation & Nobel Biocare - Research and Markets
BusinessWire - Thu Mar 31, 10:30AM CDT
Research and Markets has announced the addition of the "Bioceramics Market Analysis By Material (Alumina, Zirconia), By Application (Dental, Orthopedic) And Segment Forecasts To 2022" report to their offering.
AMDA: 0.84 (+0.01)
Amedica First to 3D Print Silicon Nitride for Medical Applications
Marketwired - Wed Mar 23, 8:15AM CDT
Amedica Corporation (NASDAQ: AMDA), a company that develops and commercializes silicon nitride ceramics as a biomaterial platform, is pleased to announce its first fabrication of complex, three-dimensional structures by a 3D printing process called robotic deposition, or robocasting. The final products have been examined under scanning electron microscopy to confirm the integrity and validity of the 3D printing method, and have been shown to achieve similar theoretical density and microstructure attributes to the traditionally manufactured silicon nitride fusion devices currently in use.
AMDA: 0.84 (+0.01)
Amedica Corporation Reports Fourth Quarter and Full Year 2015 Financial Results
GlobeNewswire - Thu Mar 17, 3:15PM CDT
2015 Revenue of $19.5 Million at High End of Guidance
AMDA: 0.84 (+0.01)
Amedica Corporation (NASDAQ: AMDA) Analyst Coverage Initiated; Earnings Analysis
ACCESSWIRE - Mon Mar 14, 7:31AM CDT
SALT LAKE CITY, UT / ACCESSWIRE / March 14, 2016 / Amedica Corporation (NASDAQ: AMDA) a commercial biomaterial company focused on using its silicon nitride technology platform to develop, manufacture and sell a range of medical devices, announced collaboration with Celling Biosciences, a leader in autologous cellular therapy technologies, to research and develop biologically enhanced implants. As part of the initial phase of the collaboration, Celling Biosciences' team of scientists produced research indicating mesenchymal stem cells can be optimized and proliferate when using silicon nitride compared to the current PEEK and titanium biomaterial standards. Results from the recent in vivo scientific study show that Amedica's proprietary silicon nitride composition significantly outperformed PEEK in attachment testing of mesenchymal stem cells.
AMDA: 0.84 (+0.01)
Amedica to Present Research Supporting Favorable Silicon Nitride Findings at the Orthopaedic Research Society Annual Meeting
GlobeNewswire - Thu Jan 28, 8:00AM CST
Amedica Corporation (Nasdaq:AMDA), a company that develops and commercializes silicon nitride ceramics as a biomaterial platform, is pleased to announce all four submissions to the Orthopaedic Research Society ("ORS" Annual Meeting were accepted for presentation occurring March 5-8, 2016 in Orlando, Florida.
AMDA: 0.84 (+0.01)
Amedica Enhances Valeo II(TM) Product Family With the Addition of Its Second Generation Cervical System
GlobeNewswire - Mon Jan 25, 7:30AM CST
Amedica Corporation (Nasdaq:AMDA), a company that develops and commercializes silicon nitride ceramics as a biomaterial platform, is pleased to announce the release of its Valeo II(TM) C interbody fusion device system. The second generation cervical system will be commercially available mid-February 2016.
AMDA: 0.84 (+0.01)
Amedica Signs International Private Label Supply Agreement With Chinese Orthopedic Company
GlobeNewswire - Wed Dec 30, 7:30AM CST
Amedica Corporation (Nasdaq:AMDA), a company that develops and commercializes silicon nitride ceramics as a biomaterial platform, today announced the execution of a private label supply agreement with BoTEC Medical, a subsidiary of WinnTi Medical Group and one of the fastest growing orthopedic companies in the People's Republic of China focused on extremity and spine solutions. This agreement marks the establishment of a long-term collaborative partnership between the two companies.
AMDA: 0.84 (+0.01)
Amedica Corporation Amends Series A and C Warrants
GlobeNewswire - Mon Dec 14, 7:45AM CST
Amedica Corporation (Nasdaq:AMDA), a company that develops and commercializes silicon nitride ceramics as a biomaterial platform, announced today that it has amended its Series A and Series C warrants with each of the warrant holders.
AMDA: 0.84 (+0.01)
ulrich medical USA® Settles Lawsuit against Amedica®
PR Newswire - Mon Dec 07, 1:07PM CST
ulrich medical USA, Inc. (ulrich) today announced it has reached a settlement with Amedica Corporation (Nasdaq: AMDA) in association with a lawsuit that ulrich filed against Amedica alleging a variety of infractions related to the hiring by Amedica of a former ulrich sales director that ulrich alleged violated the former sales director's Employment Agreement with ulrich, including its confidentiality and non-competition provisions.
AMDA: 0.84 (+0.01)
Amedica Corporation to Present at LD Micro "Main Event" Investor Conference
GlobeNewswire - Thu Nov 19, 3:15PM CST
Amedica Corporation (Nasdaq:AMDA), a company that develops and commercializes silicon nitride ceramics as a biomaterial platform, announced today that it will be presenting at LD Micro "Main Event" Investor Conference to be held December 1-3, 2015 at the Luxe Sunset Boulevard Hotel in Los Angeles.
AMDA: 0.84 (+0.01)
Amedica Corporation to Release Second Quarter 2016 Financial Results and Host Conference Call
Marketwire Canada - Mon Aug 01, 11:39AM CDT
SALT LAKE CITY, UT--(Marketwired - Aug 1, 2016) - Amedica Corporation (NASDAQ: AMDA), a company that develops and commercializes silicon nitride ceramics as a biomaterial platform, announced today that it will release financial results for its second quarter 2016 on Thursday, August 11, 2016, after the market closes.
AMDA: 0.84 (+0.01)
Why Investors Love These Medical Appliances & Equipment's Stocks? - Align Technology, ZELTIQ Aesthetics, Amedica, and Nxstage Medical
PR Newswire - Wed Jun 22, 6:45AM CDT
Growth is expected for the U.S. Medical Appliances and Equipment industry as demand for healthcare continues to rise. In today's pre-market research, Stock-Callers.com shifts its attention on these four equities for investors' close review: Align Technology Inc. (NASDAQ: ALGN), ZELTIQ Aesthetics Inc. (NASDAQ: ZLTQ), Amedica Corp. (NASDAQ: AMDA), and Nxstage Medical Inc. (NASDAQ: NXTM). Learn more about these stocks and receive your complimentary trade alerts at:
NXTM: 22.09 (-0.02), ZLTQ: 33.57 (-0.38), ALGN: 89.69 (+0.54), AMDA: 0.84 (+0.01)
Amedica Corporation Reports First Quarter 2016 Financial Results
Marketwire Canada - Thu May 12, 3:25PM CDT
Q1 Operational Cash Burn Improved by 51% Year-Over-Year
AMDA: 0.84 (+0.01)
Amedica Completes Debt Exchange and Reduces Debt Obligations by 47% Year-Over-Year
Marketwired - Tue May 03, 8:15AM CDT
Amedica Corporation (NASDAQ: AMDA), a company that develops and commercializes silicon nitride ceramics as a biomaterial platform, is pleased to announce it has reduced its total debt obligations to $12.9 million, a decrease of 47% from the prior year period, with the completion of the previously announced $3.0 million debt exchange.
AMDA: 0.84 (+0.01)
Amedica Corporation to Release First Quarter 2016 Financial Results and Host Conference Call
Marketwired - Fri Apr 29, 3:30PM CDT
Amedica Corporation (NASDAQ: AMDA), a company that develops and commercializes silicon nitride ceramics as a biomaterial platform, announced today that it will release financial results for its first quarter 2016 on Thursday, May 12, 2016, after the market closes.
AMDA: 0.84 (+0.01)
Amedica Signs Exclusive Chinese Silicon Nitride Distribution Agreement
Marketwired - Mon Apr 18, 8:15AM CDT
Amedica Corporation (NASDAQ: AMDA), a company that develops and commercializes silicon nitride ceramics as a biomaterial platform, is pleased to announce a partnership with Shandong Weigao Orthopedic Device Company Limited ("Weigao Orthopedic"
, a subsidiary of Shandong Weigao Group Medical Polymer Company Limited (HKSE: 1066), a medical device company in China specializing in the R&D, production and sale of spine, trauma and joint orthopedic implants. AMDA: 0.84 (+0.01)
Positive Economic Trends Bode Well for Manufacturers, According to Keynote on Day Two of IQMS Pinnacle User Conference
BusinessWire - Thu Apr 07, 3:00PM CDT
The US and international economies are having some impact on the demand for manufactured goods, but positive trends--including a spike in future orders--point to growth in the manufacturing sector. That was theme of the keynote on Day Two of the Pinnacle conference for customers of IQMS, a leading manufacturing ERP software and manufacturing execution system (MES) authority. The keynote session, "Five Reasons to Set Your Hair on Fire and Five Directions to Chill," was delivered by Dr. Christopher Kuehl, co-founder, managing director, and the lead economic analyst at Armada Corporate Intelligence.
AMDA: 0.84 (+0.01)
Amedica Enters Debt Exchange Agreement
Marketwired - Tue Apr 05, 8:15AM CDT
Amedica Corporation (NASDAQ: AMDA), a company that develops and commercializes silicon nitride ceramics as a biomaterial platform, is pleased to announce it has entered into a debt exchange agreement with Riverside Merchant Partners, LLC, Hercules Technology III, L.P. and Hercules Capital, Inc. Amedica agreed to exchange $1.0 million of the principal amount outstanding under the term loan held by Riverside for a subordinated convertible promissory note in the principal amount of $1.0 million and a warrant to purchase 100,000 shares of common stock. The subordinated convertible promissory note is convertible into shares of common stock at a fixed conversion price of $1.43 and the exercise price of the warrant is fixed at $1.62 per share. The subordinated convertible promissory note bears interest at a rate of 6% per annum and is due March 3, 2018.
AMDA: 0.84 (+0.01)
Bioceramics Market Analysis - Key Players are CeramTec, Amedica Corporation & Nobel Biocare - Research and Markets
BusinessWire - Thu Mar 31, 10:30AM CDT
Research and Markets has announced the addition of the "Bioceramics Market Analysis By Material (Alumina, Zirconia), By Application (Dental, Orthopedic) And Segment Forecasts To 2022" report to their offering.
AMDA: 0.84 (+0.01)
Amedica First to 3D Print Silicon Nitride for Medical Applications
Marketwired - Wed Mar 23, 8:15AM CDT
Amedica Corporation (NASDAQ: AMDA), a company that develops and commercializes silicon nitride ceramics as a biomaterial platform, is pleased to announce its first fabrication of complex, three-dimensional structures by a 3D printing process called robotic deposition, or robocasting. The final products have been examined under scanning electron microscopy to confirm the integrity and validity of the 3D printing method, and have been shown to achieve similar theoretical density and microstructure attributes to the traditionally manufactured silicon nitride fusion devices currently in use.
AMDA: 0.84 (+0.01)
Amedica Corporation Reports Fourth Quarter and Full Year 2015 Financial Results
GlobeNewswire - Thu Mar 17, 3:15PM CDT
2015 Revenue of $19.5 Million at High End of Guidance
AMDA: 0.84 (+0.01)
Amedica Corporation (NASDAQ: AMDA) Analyst Coverage Initiated; Earnings Analysis
ACCESSWIRE - Mon Mar 14, 7:31AM CDT
SALT LAKE CITY, UT / ACCESSWIRE / March 14, 2016 / Amedica Corporation (NASDAQ: AMDA) a commercial biomaterial company focused on using its silicon nitride technology platform to develop, manufacture and sell a range of medical devices, announced collaboration with Celling Biosciences, a leader in autologous cellular therapy technologies, to research and develop biologically enhanced implants. As part of the initial phase of the collaboration, Celling Biosciences' team of scientists produced research indicating mesenchymal stem cells can be optimized and proliferate when using silicon nitride compared to the current PEEK and titanium biomaterial standards. Results from the recent in vivo scientific study show that Amedica's proprietary silicon nitride composition significantly outperformed PEEK in attachment testing of mesenchymal stem cells.
AMDA: 0.84 (+0.01)
Amedica to Present Research Supporting Favorable Silicon Nitride Findings at the Orthopaedic Research Society Annual Meeting
GlobeNewswire - Thu Jan 28, 8:00AM CST
Amedica Corporation (Nasdaq:AMDA), a company that develops and commercializes silicon nitride ceramics as a biomaterial platform, is pleased to announce all four submissions to the Orthopaedic Research Society ("ORS"
Annual Meeting were accepted for presentation occurring March 5-8, 2016 in Orlando, Florida. AMDA: 0.84 (+0.01)
Amedica Enhances Valeo II(TM) Product Family With the Addition of Its Second Generation Cervical System
GlobeNewswire - Mon Jan 25, 7:30AM CST
Amedica Corporation (Nasdaq:AMDA), a company that develops and commercializes silicon nitride ceramics as a biomaterial platform, is pleased to announce the release of its Valeo II(TM) C interbody fusion device system. The second generation cervical system will be commercially available mid-February 2016.
AMDA: 0.84 (+0.01)
Amedica Signs International Private Label Supply Agreement With Chinese Orthopedic Company
GlobeNewswire - Wed Dec 30, 7:30AM CST
Amedica Corporation (Nasdaq:AMDA), a company that develops and commercializes silicon nitride ceramics as a biomaterial platform, today announced the execution of a private label supply agreement with BoTEC Medical, a subsidiary of WinnTi Medical Group and one of the fastest growing orthopedic companies in the People's Republic of China focused on extremity and spine solutions. This agreement marks the establishment of a long-term collaborative partnership between the two companies.
AMDA: 0.84 (+0.01)
Amedica Corporation Amends Series A and C Warrants
GlobeNewswire - Mon Dec 14, 7:45AM CST
Amedica Corporation (Nasdaq:AMDA), a company that develops and commercializes silicon nitride ceramics as a biomaterial platform, announced today that it has amended its Series A and Series C warrants with each of the warrant holders.
AMDA: 0.84 (+0.01)
ulrich medical USA® Settles Lawsuit against Amedica®
PR Newswire - Mon Dec 07, 1:07PM CST
ulrich medical USA, Inc. (ulrich) today announced it has reached a settlement with Amedica Corporation (Nasdaq: AMDA) in association with a lawsuit that ulrich filed against Amedica alleging a variety of infractions related to the hiring by Amedica of a former ulrich sales director that ulrich alleged violated the former sales director's Employment Agreement with ulrich, including its confidentiality and non-competition provisions.
AMDA: 0.84 (+0.01)
Amedica Corporation to Present at LD Micro "Main Event" Investor Conference
GlobeNewswire - Thu Nov 19, 3:15PM CST
Amedica Corporation (Nasdaq:AMDA), a company that develops and commercializes silicon nitride ceramics as a biomaterial platform, announced today that it will be presenting at LD Micro "Main Event" Investor Conference to be held December 1-3, 2015 at the Luxe Sunset Boulevard Hotel in Los Angeles.
AMDA: 0.84 (+0.01)
